LCAT and osteoporosis: A recent investigation conducted by Liu et al. of the metabolic perturbations caused by the administration of estradiol in osteoporosis patients revealed the central role of glycerophospholipid metabolism, which was further verified by changes in the activity level of phosphatidylcholine-sterol acyltransferase and in the concentration of lipid peroxidative products [31].